Planta Med 2001; 67(5): 417-422
DOI: 10.1055/s-2001-15816
Original Paper
Pharmacology
© Georg Thieme Verlag Stuttgart · New York

Effects of Ginsenosides from Panax ginseng on Cell-to-Cell Communication Function Mediated by Gap Junctions

You-Wei Zhang1,2,*, De-Qiang Dou1 , Lei Zhang1 , Yin-Jie Chen1 , Xin-Sheng Yao1
  • 1 Division of Natural Products Chemistry, Shen Yang Pharmaceutical University, Shen Yang, China
  • 2 Present address: Department of Physiological Chemistry, Tokyo Medical & Dental University, Tokyo, Japan
Further Information

Publication History

July 24, 2000

October 25, 2000

Publication Date:
31 December 2001 (online)

Abstract

Gap junctions have been shown or are believed to be involved in the pathogenesis of many inherited and acquired human diseases. Agents that regulate the gap junction-mediated intercellular communication (GJIC) function may facilitate prevention and treatment of GJIC-involved diseases. In the present study we examined the effects of 27 ginsenosides isolated from Panax ginseng on GJIC. The results show that compounds 1 (oleanolic acid), 2 (ginsenoside-R0), 3 (ginsenoside-Rb1), 5 (ginsenoside-Rb2), 7 (ginsenoside-Rd), 8 (ginsenoside-Rg3), 12 (panaxadial), 13 (notoginsenoside-R4), 17 [ginsenoside-Rg2 (20S)], 18 (ginsenoside-Rf), and 26 (ginsenoside-F3) did not obviously affect GJIC, whereas compounds 4 (ginsenoside-Rc), 6 (ginsenoside-Rb3), 9 (ginsenoside-Rd2), 10 (notoginsenoside-Fe), 11 (ginsenoside-Rh2), 14 (ginsenoside-Ra1), 15 (ginsenoside-Re), 16 [ginsenoside-Rg2 (20R)], 19 (ginsenoside-Ia), 20 [ginsenoside-Rh1 (20S)], 21 [ginsenoside-Rh1 (20R)], 22 (ginsenoside-F1), 23 (protopanaxatriol), 24 (panaxatriol), 25 (ginsenoside-Rg1), and 27 (chikusetsaponin-L8) induced GJIC reductions at various degrees. Compounds 2, 7, and 8 protected against the tyrosine phosphatase inhibitor vanadate-induced GJIC reduction, while compounds 1, 5, 7, and 17 inhibited the cytokine interleukin 1 alpha (IL-1α)-induced reduction in GJIC. Nevertheless, no compounds protected against the protein kinase C (PKC) activator 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced GJIC inhibition. On the other hand, GJIC reductions induced by compounds 6, 9, 10, 20, 21, 22, 24, and 25 were inhibited by the tyrosine kinase (TK) inhibitor genistein, while GJIC reductions induced by compounds 6, 9, 14, 16, 19, 21, and 24 were attenuated in the presence of the PKC inhibitor calphostin C. However, GJIC reductions induced by compounds 4, 23, and 27 were not inhibited either by genistein or by calphostin C. These data indicate that various mechanisms are responsible for effects of ginsenosides on GJIC.

References

  • 1 Kumur N M, Gilula N B. Cloning and characterization of human and rat liver cDNAs coding for a gap junction protein.  Journal of Cell Biology. 1986;  103 767-76
  • 2 Carystinos G D, Katabi M M, Laird D W, Galipeau J, Chan H, Alaoui-Jamali M A, Batist G. Cyclic-AMP induction of gap junctional intercellular communication increases bystander effect in suicide gene therapy.  Clinical Cancer Research. 1999;  5 61-8
  • 3 Zhang W, Couldwell W T, Simard M F, Song H, Lin J HC, Nedergaard M. Direct gap junction communication between malignant glioma cells and astrocytes.  Cancer Research. 1999;  59 1994-2003
  • 4 Paul D L. New functions for gap junctions.  Current Opinion Cell Biology. 1995;  7 665-72
  • 5 Unger V M, Kumar N M, Gilula N B, Yeager M. Three-dimensional structure of a recombinant gap junction membrane channel.  Science. 1999;  283 1176-80
  • 6 Kumar N M, Gilula N B. The gap junction communication channel.  Cell. 1996;  84 381-8
  • 7 Laird D W, Revel J P. Biochemical and immunochemical analysis of the arrangement of connexin43 in rat heart gap junction membranes.  Journal Cell Science. 1990;  97 109-17
  • 8 Nicholson S M, Bruzzone R. Gap junctions : getting the message through.  Current Biology. 1997;  7 R340-4
  • 9 Tsai H, Werber J, Davia M O, Edelman M, Tanaka K E, Melman A, Christ G J, Geliebter J. Reduced connexin43 expression in high grade, human prostatic adenocarcinoma cells.  Biochemical & Biopyhsical Research Communication. 1996;  227 64-9
  • 10 Hillis G S, Duthie L A, Brown P A, Simpson J G, Macleod A M, Haites N E. Upregulation and co-localization of connexin43 and cellular adhesion molecules in inflammatory renal disease.  Journal of Pathology. 1997;  182 373-9
  • 11 Yeh H I, Lupu F, Dupont E, Severs N J. Upregulation of connexin43 gap junctions between smooth muscle cells after balloon catheter injury in the rat carotid artery.  Arteriosclerosis, Thrombosis & Vascular Biology. 1997;  17 3174-84
  • 12 Mussini I, Biral D, Marin O, Furlan S, Salvatori S. Myotonic dystrophy protein kinase expressed in rat cardiac muscle is associated with sarcoplasmic reticulum and gap junctions.  Journal of Histochemistry & Cytochemistry. 1999;  47 383-92
  • 13 Zhang Y W, Morita I, Nishida M, Murota S. Involvement of tyrosine kinase in the hypoxia/reoxygenation-induced gap junctional intercellular communication abnormality in cultured human umbilical vein endothelial cells.  Journal of Cellular Physiology. 1999;  180 305-13
  • 14 Green L M, LaBue M, Lazarus J P, Jennings J C. Reduced cell-cell communication in experimentally induced autoimmune thyroid disease.  Endocrinology. 1996;  137 2823-32
  • 15 Peters N S. New insights into myocardial arrhythmyogenesis distribution of gap-junctional coupling in normal, ischemic and hypertrophied human hearts.  Clinical Science. 96;  90 447-52
  • 16 Nagy J I, Li W, Hertzberg E L, Marotta C A. Elevated connexin43 immunoreactivity at sites of amyloid plaques in Alzheimer’s disease.  Brain Research. 1996;  717 173-8
  • 17 Kretzer F L, Mehta R S, Johnson A T, Hunter D G, Brown E S, Hirtner H M. Vitamin E protects retinopathy through action on spindle cells.  Nature. 1984;  309 793-5
  • 18 Zhang Y W, Morita I, Yao X S, Murota S. Pretreatment with eicasapentaenoic acid prevented hypoxia/reoxygenation-induced abnormality in endothelial gap junctional intercellular communication through inhibiting the tyrosine kinase activity.  Prostaglandins, Leukotrienes & Essential Fatty Acid. 1999;  61 33-40
  • 19 Zhang Y W, Morita I, Shao G, Yao X S, Murota S. Screening of anti-hypoxia/reoxygenation agents by an in vitro model. Part 1: Natural inhibitors for protein tyrosine kinase activated by hypoxia/reoxygenation in cultured human umbilical vein endothelial cells.  Planta Medica. 2000;  66 114-8
  • 20 Zhang Y W, Morita I, Zhang L, Shao G, Yao X S, Murota S. Screening of anti-hypoxia/reoxygenation agents by an in vitro model. Part 2: Inhibition of tyrosine kinase activation prevented hypoxia/reoxygenation-induced injury in endothelial gap junctional intercellular communication.  Planta Medica. 2000;  66 119-23
  • 21 Dou D Q, Zhang Y W, Zhang L, Chen Y J, Yao X S. The inhibitory effects of ginsenosides on protein tyrosine kinase activated by hypoxia/reoxygenation in cultured human umbilical vein endothelial cells.  Planta Medica. 2001;  67 19-23
  • 22 Hutcheson I R, Chaytor A T, Evans W H, Griffith T M. Nitric oxide-independent relaxations to acetylcholine and A23187 involve different routes of heterocellular communication. Role of gap junctions and phospholipase A2.  Circulation Research. 1999;  84 53-63

Dr You-Wei Zhang

Room 201

Masakikoupu

4-2-12 Kita-Koiwa

Edogawa Ku

133-0051 Tokyo

Japan

Email: zywlcell@yahoo.com

Phone: Tel. and Fax: +81-3-5694-4940

    >